{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:38:02Z","timestamp":1778503082431,"version":"3.51.4"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,8,1]]},"abstract":"<jats:p>The Food and Drug Administration licensed a live-virus varicella vaccine (Varivax; Merck &amp; Co Inc, West Point, PA) in March 1995. Prelicensure adverse events were minimal; however, since licensure and increased vaccine use, rare previously undetected risks have arisen. Presented here is the clinical course of a previously undiagnosed, human immunodeficiency virus-infected boy who developed dissemination of the vaccine strain of varicella zoster after immunization. chickenpox, human immunodeficiency virus, pneumonia, encephalopathy, varicella vaccine, adverse events, dissemination.<\/jats:p>","DOI":"10.1542\/peds.108.2.e39","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"e39-e39","source":"Crossref","is-referenced-by-count":65,"title":["Disseminated Vaccine Strain Varicella as the Acquired Immunodeficiency Syndrome-Defining Illness in a  Previously Undiagnosed Child"],"prefix":"10.1542","volume":"108","author":[{"given":"J. Michael","family":"Kramer","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Divisions of Infectious Diseases,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"LaRussa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan C.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Pulmonary,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Carney","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Leber","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Gahagan","sequence":"additional","affiliation":[{"name":"General Pediatrics, University of Michigan, Ann Arbor, Michigan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Pulmonary,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Alexander","family":"Blackwood","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Divisions of Infectious Diseases,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2001,8,1]]},"reference":[{"key":"2021121003535777600_B1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","article-title":"Postlicensure safety surveillance for varicella vaccine.","volume":"284","author":"Wise","year":"2000","journal-title":"JAMA"},{"key":"2021121003535777600_B2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","article-title":"The postmarketing safety profile of varicella vaccine.","volume":"19","author":"Sharrar","year":"2001","journal-title":"Vaccine"},{"key":"2021121003535777600_B3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00007611-199401000-00016","article-title":"Varicella immunity and clinical disease in HIV-infected adults.","volume":"87","author":"Wallace","year":"1994","journal-title":"South Med J"},{"key":"2021121003535777600_B4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00006454-199509000-00003","article-title":"Varicella vaccine: its past, present and future.","volume":"14","author":"Gershon","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003535777600_B5","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1093\/infdis\/174.Supplement_3.S320","article-title":"Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada.","volume":"174","author":"LaRussa","year":"1996","journal-title":"J Infect Dis"},{"key":"2021121003535777600_B6"},{"key":"2021121003535777600_B7","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1093\/clinids\/17.Supplement_2.S368","article-title":"Prevention of infections in patients with T-cell defects.","volume":"11","author":"Hughes","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2021121003535777600_B8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000416850","article-title":"Reinfection with varicella-zoster virus in immunocompromised patients.","volume":"18","author":"Junker","year":"1989","journal-title":"Curr Probl Dermatol"},{"key":"2021121003535777600_B9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0025-7125(16)31167-1","article-title":"Viral infections in immunocompromised patients.","volume":"67","author":"Wong","year":"1983","journal-title":"Med Clin North Am"},{"key":"2021121003535777600_B10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/jvi.66.2.1016-1020.1992","article-title":"Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.","volume":"66","author":"LaRussa","year":"1992","journal-title":"J Virol"},{"key":"2021121003535777600_B11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","article-title":"Varicella in children with cancer: seventy-seven cases.","volume":"56","author":"Feldman","year":"1975","journal-title":"Pediatrics"},{"key":"2021121003535777600_B12"},{"key":"2021121003535777600_B13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(94)70317-5","article-title":"Varicella in children with perinatally acquired human immunodeficiency virus infection.","volume":"124","author":"Kelley","year":"1994","journal-title":"J Pediatr"},{"key":"2021121003535777600_B14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1086\/514147","article-title":"Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.","volume":"176","author":"Gershon","year":"1997","journal-title":"J Infect Dis"},{"key":"2021121003535777600_B15"},{"key":"2021121003535777600_B16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00006454-199602000-00005","article-title":"Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection.","volume":"15","author":"Izraeli","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003535777600_B17"},{"key":"2021121003535777600_B18","first-page":"S329","article-title":"Autoimmunity in the pathogenesis of HIV-related peripheral neuropathy.","volume":"39","author":"Bredesen","year":"1989","journal-title":"Neurology"},{"key":"2021121003535777600_B19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000112906","article-title":"Varicella with acute motor axonal neuropathy.","volume":"38","author":"Picard","year":"1997","journal-title":"Eur Neurol"},{"key":"2021121003535777600_B20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.38.7.1150","article-title":"Chronic progressive varicella-zoster virus encephalitis in an AIDS patient.","volume":"38","author":"Gilden","year":"1988","journal-title":"Neurology"},{"key":"2021121003535777600_B21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/brain\/117.5.987","article-title":"Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome.","volume":"117","author":"Gray","year":"1994","journal-title":"Brain"},{"key":"2021121003535777600_B22","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.44.10.1818","article-title":"Varicella-zoster virus myelitis: an expanding spectrum.","volume":"44","author":"Gilden","year":"1994","journal-title":"Neurology"},{"key":"2021121003535777600_B23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jmv.1890420404","article-title":"Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient.","volume":"42","author":"Snoeck","year":"1994","journal-title":"J Med Virol"},{"key":"2021121003535777600_B24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF00294307","article-title":"Acute varicella-zoster virus ventriculitis and meningo-myelo-radiculitis in acquired immunodeficiency syndrome.","volume":"86","author":"Chretien","year":"1993","journal-title":"Acta Neuropathol (Berl)"},{"key":"2021121003535777600_B25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.410140404","article-title":"Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.","volume":"14","author":"Snider","year":"1983","journal-title":"Ann Neurol"},{"key":"2021121003535777600_B26","first-page":"273","article-title":"Detection of varicella-zoster virus DNA using the polymerase chain reaction in an immunocompromised patient with transverse myelitis secondary to herpes zoster.","volume":"69","author":"Grant","year":"1993","journal-title":"Genitourin Med"},{"key":"2021121003535777600_B27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0022-3476(05)81748-2","article-title":"Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome.","volume":"123","author":"Silliman","year":"1993","journal-title":"J Pediatr"},{"key":"2021121003535777600_B28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.1988.00520340038008","article-title":"The neuromuscular manifestations of human immunodeficiency virus infections.","volume":"45","author":"Lange","year":"1988","journal-title":"Arch Neurol"},{"key":"2021121003535777600_B29","first-page":"161","article-title":"Neurological manifestations of acquired immunodeficiency syndrome in children.","volume":"4","author":"Mintz","year":"1989","journal-title":"Int Pediatr"},{"key":"2021121003535777600_B30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(05)80491-3","article-title":"Inflammatory demyelinating polyneuropathy in a child with symptomatic human immunodeficiency virus infection.","volume":"118","author":"Raphael","year":"1991","journal-title":"J Pediatr"},{"key":"2021121003535777600_B31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","article-title":"Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine.","volume":"127","author":"Krause","year":"1995","journal-title":"J Pediatr"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/2\/e39\/1164787\/e39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/2\/e39\/1164787\/e39.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:22:37Z","timestamp":1639135357000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/2\/e39\/63719\/Disseminated-Vaccine-Strain-Varicella-as-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,8,1]]},"published-print":{"date-parts":[[2001,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.2.e39","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}